Company Filing History:
Years Active: 2016
Title: Michael Lebens - Innovator in Vaccine Development
Introduction
Michael Lebens is a notable inventor based in Hökerum, Sweden. He has made significant contributions to the field of vaccine development, particularly in combating cholera and enterotoxigenic Escherichia coli (ETEC). His innovative work has led to the creation of a vaccine that utilizes genetically modified O1 cells.
Latest Patents
Michael Lebens holds 1 patent for a vaccine against cholera and/or ETEC. This patent describes a vaccine comprising O1 cells that include O1 antigens from both Ogawa and Inaba serotypes. The invention also encompasses genetically modified O1 cells for use in such vaccines, DNA constructs for modification, and methods for vaccine production.
Career Highlights
Throughout his career, Michael Lebens has worked with several prominent organizations. He has been associated with MSD Wellcome Trust, Hilleman Laboratories Pvt. Ltd., and Gotovax AB. His work in these companies has contributed to advancements in vaccine technology and public health.
Collaborations
Michael has collaborated with esteemed colleagues in the field, including Jan Holmgren and Ann-Mari Svennerholm. Their joint efforts have furthered research and development in vaccine efficacy and safety.
Conclusion
Michael Lebens is a distinguished inventor whose work in vaccine development has the potential to save lives and improve public health. His innovative approach to combating cholera and ETEC showcases the importance of research and collaboration in the field of medicine.